Blog

Rajat Thawani: Talking about biomarkers in lung cancer

Photo taken from Rajat Thawani/X

Sep 12, 2024, 15:39

Rajat Thawani: Talking about biomarkers in lung cancer

Rajat Thawani, Assistant Professor, University of Chicago, shared a post by Physician’s Weekly on X, adding:

“Talking about biomarkers in lung cancer. Every patients deserves testing to determine the right treatment.”

Quoting Physician’s Weekly:

“In today’s PeerPOV podcast, Rajat Thawani of University of Chicago Hematology/Oncology discusses the role of specialized biomarker testing teams & why biomarker testing is crucial in guiding treatment decisions for patients with ROS1 mutations in NSCLC. Tune in here.”

Source: Rajat Thawani/X and Physician’s Weekly/X

cancer cancer awareness fight against cancer Lung cancer NSCLC OncoDaily Oncology PeerPOV Physician's Weekly Rajat Thawani University of Chicago Hematology/Oncology

Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

Former Disney CEO Bob Chapek Appointed Senior Adviser at SCAN Group

Special Coverage